6640--Immucor Bloodbank Reagents | SAM.gov Opportunity | G2X

6640--Immucor Bloodbank Reagents

Solicitation36C24625Q0087Notice typeSpecial Notice

Attachments

1 file

Name	Type	Posted	Actions
36C24625Q0087.docx	DOCX	Oct 9, 2024	Download

Version History

6640--Immucor Bloodbank Reagents

Special Notice36C24625Q0087Oct 9, 2024 · v1

LatestViewing

Opportunity Summary

The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 6, intends to negotiate a sole source firm-fixed-price contract with Immucor, Inc. for the procurement of blood bank reagents. This brand-name requirement supports the Pathology Department at the Asheville VA Medical Center, which requires a standing order of reagents compatible with its existing Echo Lumena Blood Bank Analyzer. This procurement is classified under NAICS 325413, In-Vitro Diagnostic Substance Manufacturing, and PSC 6640, Laboratory Equipment and Supplies.

The government intends to award this contract under the authority of 41 U.S.C. 3304(a)(1) as implemented by FAR 6.302-1, having determined that Immucor, Inc. is the only responsible source capable of satisfying the agency’s requirement without unacceptable delays or duplication of costs. Although this notice does not constitute a request for competitive proposals, firms believing they can meet the requirement may submit interest and capability information to the point of contact, Daleta S. Coles.

The response deadline for solicitation number 36C24625Q0087 is October 14, 2024, at 2:00 PM EDT. The notice, originally published on October 9, 2024, includes one attachment titled 36C24625Q0087.docx. Submissions must identify the respondent's business size, socio-economic status, and ownership origin. All responses must reference the solicitation number.

Generated by Lumen AI

Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.

Opportunity Summary

Opportunity Details

Response deadline: Oct 14, 2024Expired 598 days ago
NAICS: 325413 (opens in new tab)
PSC: 6640 (opens in new tab)
Set aside: —
Published: Oct 9, 2024
Updated: Oct 9, 2024
Agency: VETERANS AFFAIRS, DEPARTMENT OF (opens in new tab)
Office: 246-NETWORK CONTRACTING OFFICE 6 (36C246)
Department: —
Source: View on SAM.gov (opens in new tab)

Contact and place of performance

Point of contact: Daleta S Coles

Place of performance: Not specified

Original Description

The Department of Veteran Affairs, Veterans Health Administration, Network Contracting Office 6, Hampton VA 23667, intends to negotiate a sole source Firm-Fixed Price contract for the procurement of Blood Bank Reagents for the Asheville VA Medical Center with Immucor, Inc.; in accordance with 41 U.S.C. 3304(a)(1) as implemented by FAR 6.302-1 Only One Responsible Source. This is not a request for competitive offers and no solicitation is available. Market research has determined that these items are highly specialized, are only available from a single source without an unacceptable delay or duplication of cost and no other type of items will satisfy agency requirements. The Government intends to award the contract with an effective date of 01 October 2019 to Immucor Inc., 3130 Gateway Drive, Norcross, GA 30071 Unique Entity ID: KV8AGJX7NMZ7. This is a Brand-Name Only requirement for the Pathology Department at the Asheville VAMC and is required due to the program having a history of utilizing the Echo Lumena Blood Bank Analyzer and requires the compatible reagents for daily operation. The Asheville VAMC Blood Bank requires a standing order for reagents. This synopsis announcement is being issued for information purposes only and does not constitute a solicitation or request for competitive proposals. If a firm believes it is capable of meeting the Government's requirement, it may identify its interest and capability to the contract specialist within three (3) calendar days of this publication by contacting Daleta Coles via e-mail at [email protected] Telephone inquiries will not be accepted. This announcement closes 14 October 2024 at 1400PM EDT. Those interested firms must indicate whether they are large, small, small-disadvantaged, 8(a) or woman owned business and whether they are U.S. or foreign owned. Respondents who submit proprietary data shall clearly mark the data with appropriate markings. The Government will not pay for any information submitted as a result of this synopsis. This synopsis shall not be construed as an obligation on the part of the Government to acquire any products or services. ***Reference RFQ 36C24625Q0087 in all replies